Clinical Trials · NCT01813097

Combination Iodine 125 Seed Implants and LHRH Agonists for Locally Advanced (Stage T3) Prostate Cancer

Name: Combination Iodine 125 Seed Implants and LHRH Agonists for Locally Advanced (Stage T3) Prostate Cancer
Creator: Peptide Science Daily
License: https://clinicaltrials.gov/about-site/terms-conditions

CompletedN/AGonadorelin

Phase: N/A
Recruitment status: Completed
Sponsor: Chinese PLA General Hospital
Enrollment: 60
Start date: Feb 2008
Locations: See registry
Primary endpoint: To detective the effect of the treatment of combination iodine 125 seed implants and LHRH agonists for the patients with locally advanced prostate cancer.

View Gonadorelin compound reference